# Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia

Study · id `cardio:ct-nct06743659` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06743659](<https://clinicaltrials.gov/study/NCT06743659>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06743659

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

## Technical summary

Registry record NCT06743659. Non-randomized; no masking; primary purpose diagnostic. Start 2025-04-01 (actual); primary completion 2027-03-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT06743659, source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)
- Started: 2025-04-01 (actual) (ClinicalTrials.gov record NCT06743659, source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)
- Primary completion: 2027-03-30 (anticipated) (ClinicalTrials.gov record NCT06743659, source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)
- Completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT06743659, source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06743659, source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06743659-2026-09-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
- Acronym: FH-ALERT
- Condition: Familial Hypercholesterolaemia
- Intervention (Device): Alert-based computerized decision support
- Lead sponsor: Brigham and Women's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Familial hypercholesterolemia (`cardio:familial-hypercholesterolemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as the lead sponsor: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)

## Provenance

Content hash: a2f4b52dcc0d81c49a2774fff4a588bcafd6790b7247b7c1d41c5b95ef6095b4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
